HOME › DRUGS › EZETIMIBE
ACTIVE SUBSTANCE / INN

EZETIMIBE

Brand name(s): NEXLIZET, EZETIMIBE, LYPQOZET, ROSZET, VYTORIN, EZETIMIBE AND SIMVASTATIN, ZETIA, LIPTRUZET
FDA LISTED
PRESCRIPTION
DISCONTINUED
ANDA201890
NDA021687
ACTIVE SUBSTANCE
Ezetimibe
REGULATORS
FDA
SPONSORS / MAH
PHARMOBEDIENT, AUROBINDO PHARMA USA, ZYDUS PHARMS
TOTAL APPLICATIONS
10
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
LIPTRUZETNDA200153ORGANONDiscontinued
EZETIMIBEANDA204331ZYDUS PHARMSPrescription
EZETIMIBEANDA208332APOTEXDiscontinued
EZETIMIBE AND SIMVASTATINANDA200082AUROBINDO PHARMA USAPrescription
EZETIMIBE AND SIMVASTATINANDA201890ANI PHARMSDiscontinued
NEXLIZETNDA211617ESPERION THERAPS INCPrescription
ZETIANDA021445ORGANONPrescription
LYPQOZETANDA206084PHARMOBEDIENTPrescription
ROSZETNDA213072ALTHERA PHARMSDiscontinued
VYTORINNDA021687ORGANONPrescription

FULL INTELLIGENCE ON EZETIMIBE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →